OraSure Technologies, Inc. (OSUR)
NASDAQ: OSUR · Real-Time Price · USD
2.855
-0.265 (-8.49%)
At close: Aug 6, 2025, 4:00 PM
2.800
-0.055 (-1.93%)
After-hours: Aug 6, 2025, 7:14 PM EDT
OraSure Technologies Market Cap
OraSure Technologies has a market cap or net worth of $213.55 million as of August 6, 2025. Its market cap has decreased by -31.24% in one year.
Market Cap
213.55M
Enterprise Value
940.37K
1-Year Change
-31.24%
Ranking
Category
Stock Price
$2.86
Market Cap Chart
Since December 1, 1998, OraSure Technologies's market cap has increased from $72.90M to $213.55M, an increase of 192.94%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 233.40M | -13.33% |
| Dec 31, 2024 | 269.30M | -55.31% |
| Dec 29, 2023 | 602.60M | 72.17% |
| Dec 30, 2022 | 350.00M | -44.09% |
| Dec 31, 2021 | 626.00M | -17.56% |
| Dec 31, 2020 | 759.30M | 53.18% |
| Dec 31, 2019 | 495.70M | -30.71% |
| Dec 31, 2018 | 715.40M | -37.45% |
| Dec 29, 2017 | 1.14B | 133.76% |
| Dec 30, 2016 | 489.30M | 34.53% |
| Dec 31, 2015 | 363.70M | -36.01% |
| Dec 31, 2014 | 568.40M | 62.54% |
| Dec 31, 2013 | 349.70M | -11.76% |
| Dec 31, 2012 | 396.30M | -7.88% |
| Dec 30, 2011 | 430.20M | 61.85% |
| Dec 31, 2010 | 265.80M | 13.93% |
| Dec 31, 2009 | 233.30M | 38.21% |
| Dec 31, 2008 | 168.80M | -59.27% |
| Dec 31, 2007 | 414.40M | 9.17% |
| Dec 29, 2006 | 379.60M | -5.45% |
| Dec 30, 2005 | 401.50M | 34.10% |
| Dec 31, 2004 | 299.40M | -14.36% |
| Dec 31, 2003 | 349.60M | 70.87% |
| Dec 31, 2002 | 204.60M | -54.74% |
| Dec 31, 2001 | 452.10M | 50.80% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.62B |
| Johnson & Johnson | 411.20B |
| AbbVie | 350.75B |
| AstraZeneca | 231.42B |
| UnitedHealth Group | 227.69B |
| Abbott Laboratories | 227.46B |
| Novartis AG | 226.38B |
| Novo Nordisk | 210.71B |